Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_assertion type Assertion NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_head.
- NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_assertion wasGeneratedBy ECO_0000203 NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_provenance.
- NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_assertion wasDerivedFrom befree-20140225 NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_provenance.
- NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_assertion SIO_000772 21478295 NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_provenance.
- NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_assertion evidence source_evidence_literature NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_provenance.
- NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_assertion description "[In conclusion, our study has revealed a new mode of PI3K alteration in primary endometrial tumors and warrants future studies to determine whether PIK3R1 mutations correlate with clinical outcome to targeted therapies directed against the PI3K pathway in EEC and NEEC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169419.RAZ7RTUI8Khx9oIAxAkw-63K7yMOv64nK_0p1SBLfVUv4130_provenance.